Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Immunology Text: Biotechnology Demystified Sharon Walker Chapter 5 & 6 The immune system • An army of many types of cells in your body that defend against disease. • Designed to destroy and remove foreign material • Immune system also detects and eliminates abnormal cells (cancer) and cells that are infected (virus, bacteria) • Progenitors of the immune cells are produced in the bone marrow. • White blood cells (leukocytes) – Monocytes/macrophages eat bacteria and damaged cells – Neutrophils secrete toxic chemicals to destroy nearby cells – Lymphocytes Lymphocytes produce antibodies & mediate immune response • B-lymphocytes mature in the bone marrow – Produce antibodies • T-lymphocytes mature in the thymus – Mediate immune response – Include CD-4 cells that get infected by HIV Antigens • Molecules that provoke an immune response • Antigens may be proteins, lipids, or carbohydrates on the surface of a virus or bacterium • An antigen may have several sites that the immune system recognizes. Each site is an epitope. Cell surface antigens • Molecules on the cell surface can be antigenic • Bacteria have many surface molecules that your immune system recognizes are foreign • If you receive cells from another person (blood transfusion, transplant) they can provoke an immune response (rejection) that may require immunosuppresive therapy Antibodies • Molecules produced by B-lymphocytes • Recognize and bind to antigens • Each antibody is specific for one epitope Antibody binding to an antigen • Each B-lymphocyte produces one specific antibody • Until the B-lymphocyte encounters its antigen, it is in a resting state (naïve) with its antibodies sticking out hopefully from its surface • When an antigen encounters a B-lymphocyte with a “matching” antibody on its surface, the antigen is bound to the antibody. B-lymphocyte encounters its antigen • After the antibody/antigen complex has been formed, the B-lymphocyte is activated. • The antibodies it produces are modified so that, instead of protruding from the cell surface, they are secreted into the blood. • In addition, the B-lymphocyte starts to divide rapidly, making many clones of itself, all producing the same antibody. Antibodies have different antigen affinity Antibodies form complex with target antigen • After the antigen is eliminated, some of the Blymphocytes remain in circulation • If the same antigen is encountered later, this population of circulating cells enables a faster response • This amplified response provides immunity against the antigen. • Most effective against antigens that have repetitive structure, such as carbohydrates, lipids, or nucleic acids. Less effective against proteins. • How does the body create antibodies that are specific for antigens it has never seen? • Millions of B-lymphocyte are generated, each with a different antibody. • It is just chance that an antigen matches an antibody. Cell-mediated immunity • Viruses and some bacteria enter cells, so they are hidden from B-lymphocyte and circulating antibodies. • In these cases, macrophages, natural killer cells (NKCs) and killer T-cells attack and destroy the infected cells. • Killer T-cells also attack cancer cells Immune response to proteins • Response to proteins involves multiple types of immune cells • When a complex antigen such as a protein is enters the body, it is ingested by an antigen-presenting cell (APC), typically a macrophage or dendritic cells. • The APC breaks the antigen into small pieces and “presents” these pieces on its surface. • T-cells detect the presented antigen fragments, and initiate a cascade of responses involving antibodies or cellmediated response. Monoclonal antibodies • Monoclonal antibodies (mAbs) are produced by clones of a single B-lymphocyte. • B-lymphocyte that produce mAbs against specific antigens can be identified and grown in the lab. Monoclonal antibodies • Metastatic breast cancers have many copies of the growth factor protein Her2 on their cell surface. • Genentech developed an anti-Her2 mAb called Herceptin, used to treat metastatic breast cancer. Self-recognition • How does your immune system know what is you (self) versus what is foreign? Self-recognition • During fetal development, and for a few months after birth, the immune system “learns” that everything it sees is “self”. • Later, if a new antigen is presented, the immune system considers it to be foreign. Auto-immune disease • The immune system sometimes makes mistakes. • Self tissue may be recognized as foreign, and attacked by the immune system: auto-immune disease • These errors may be caused by antibodies that have cross-reactivity: they have high affinity for an antigen that is similar to a self tissue. The self tissue later becomes the target of the immune cells, which by feedback develop a stronger and stronger response. Auto-immune disease • Multiple sclerosis: immune system attacks self-antigens in the nervous system • Rheumatoid arthritis, lupus, diabetes, have auto-immune components. • If we understand the genes that regulate the immune system, we may be able to increase or decrease immune responses.